Profile of COVID in-patients treated in a tertiary health care center, Kerala

---

Original Article

Author Details : C V Andrews*, Ann Reshma Rajan, Sreelakshmi Arun, Praveenlal Kuttichira

Volume : 9, Issue : 3, Year : 2022

Article Page : 144-147

https://doi.org/10.18231/j.jchm.2022.028

Suggest article by email

Get Permission

---

Abstract

Covid 19 is a contagious disease caused by SARS Cov 2 which causes acute respiratory syndrome. The usual disease presentation symptoms include fever, cough, fatigue, shortness of breath, vomiting, loss of taste or smell. Some cases may be asymptomatic. Complications include pneumonia, viral sepsis, acute respiratory distress syndrome (ARDS), kidney failure and death.This study was conducted to explore the demographic profile of Covid 19 patients admitted, their clinical presentations, treatment received and outcome; so that effective management and prevention of complications can be done in the future. Out of total of 613 In-patients selected randomly, random start was decided and every 5 patient was selected for the study which gave us a sample size of 123. Out of 123, 107 (83.6%) were symptomatic at the time of seeking admission.73 (57%) of them had any pre-existing co-morbidity. Among pre-existing co-morbidities, diabetes and hypertension were noted to be of the highest frequency. Out of 123 admitted cases, (11.7%) succumbed to the disease and its complications, (75%) recovered and were discharged.

Keywords: COVID­19, Complications, Deaths, Diabetes Mellitus, Hypertension, Mortality, Morbidity, Profile, SARS Cov 2

How to cite : Andrews C V, Rajan A R, Arun S, Kuttichira P, Profile of COVID in-patients treated in a tertiary health care center, Kerala. J Community Health Manag 2022;9(3):144-147

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.